The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution.
Artificial intelligence
Diagnostic
Molecular genetics
Omics
Therapy
Journal
Functional & integrative genomics
ISSN: 1438-7948
Titre abrégé: Funct Integr Genomics
Pays: Germany
ID NLM: 100939343
Informations de publication
Date de publication:
16 Aug 2024
16 Aug 2024
Historique:
received:
02
07
2024
accepted:
05
08
2024
revised:
01
08
2024
medline:
16
8
2024
pubmed:
16
8
2024
entrez:
15
8
2024
Statut:
epublish
Résumé
Artificial intelligence (AI) platforms have emerged as pivotal tools in genetics and molecular medicine, as in many other fields. The growth in patient data, identification of new diseases and phenotypes, discovery of new intracellular pathways, availability of greater sets of omics data, and the need to continuously analyse them have led to the development of new AI platforms. AI continues to weave its way into the fabric of genetics with the potential to unlock new discoveries and enhance patient care. This technology is setting the stage for breakthroughs across various domains, including dysmorphology, rare hereditary diseases, cancers, clinical microbiomics, the investigation of zoonotic diseases, omics studies in all medical disciplines. AI's role in facilitating a deeper understanding of these areas heralds a new era of personalised medicine, where treatments and diagnoses are tailored to the individual's molecular features, offering a more precise approach to combating genetic or acquired disorders. The significance of these AI platforms is growing as they assist healthcare professionals in the diagnostic and treatment processes, marking a pivotal shift towards more informed, efficient, and effective medical practice. In this review, we will explore the range of AI tools available and show how they have become vital in various sectors of genomic research supporting clinical decisions.
Identifiants
pubmed: 39147901
doi: 10.1007/s10142-024-01417-9
pii: 10.1007/s10142-024-01417-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
138Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Abdallah S, Sharifa M, ALMADHOUN IKH, MK et al (2023) The impact of Artificial Intelligence on optimizing diagnosis and treatment plans for Rare Genetic disorders. Cureus 15. https://doi.org/10.7759/cureus.46860
Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7
Aguet F, Barbeira AN, Bonazzola R et al (2019) The GTEx Consortium atlas of genetic regulatory effects across human tissues. bioRxiv 787903. https://doi.org/10.1101/787903
Aksenov AA, Laponogov I, Zhang Z et al (2021) Auto-deconvolution and molecular networking of gas chromatography–mass spectrometry data. Nat Biotechnol 39:169–173. https://doi.org/10.1038/s41587-020-0700-3
doi: 10.1038/s41587-020-0700-3
pubmed: 33169034
Al Aboud NM, Jialal I (2018) Genetics, Epigenetic Mechanism
Alves VM, Korn D, Pervitsky V et al (2022) Knowledge-based approaches to drug discovery for rare diseases. Drug Discov Today 27:490–502
doi: 10.1016/j.drudis.2021.10.014
pubmed: 34718207
Athanasopoulou K, Boti MA, Adamopoulos PG et al (2022) Third-generation sequencing: the spearhead towards the radical transformation of modern genomics. Life 12. https://doi.org/10.3390/life12010030
Ayers JW, Poliak A, Dredze M et al (2023) Comparing physician and Artificial Intelligence Chatbot responses to patient questions posted to a Public Social Media Forum. JAMA Intern Med 183:589–596. https://doi.org/10.1001/jamainternmed.2023.1838
doi: 10.1001/jamainternmed.2023.1838
pubmed: 37115527
pmcid: 10148230
Balvers M, Gordijn IF, Voskamp-Visser IAI et al (2023) Proteome2virus: shotgun mass spectrometry data analysis pipeline for virus identification. J Clin Virol Plus 3:100147. https://doi.org/10.1016/j.jcvp.2023.100147
Bannister JJ, Crites SR, Aponte JD et al (2020) Fully automatic landmarking of syndromic 3D facial surface scans using 2D images. Sens (Switzerland) 20:1–14. https://doi.org/10.3390/s20113171
doi: 10.3390/s20113171
Basel D (2020) Dysmorphology in a genomic era. Clin Perinatol 47:15–23
doi: 10.1016/j.clp.2019.10.009
pubmed: 32000922
Bhatia HS, Brunner AD, Öztürk F et al (2022) Spatial proteomics in three-dimensional intact specimens. Cell 185:5040–5058. .e19
doi: 10.1016/j.cell.2022.11.021
pubmed: 36563667
Bhinder B, Gilvary C, Madhukar NS, Elemento O (2021) Artifi Cial intelligence in cancer research and precision medicine. Cancer Discov 11:900–915. https://doi.org/10.1158/2159-8290.CD-21-0090
doi: 10.1158/2159-8290.CD-21-0090
pubmed: 33811123
pmcid: 8034385
Bilitchenko L, Liu A, Densmore D (2011) The Eugene language for synthetic biology. In: Methods in Enzymology. pp 153–172
Boniolo F, Dorigatti E, Ohnmacht AJ et al (2021) Artificial intelligence in early drug discovery enabling precision medicine. Expert Opin Drug Discov 16:991–1007
doi: 10.1080/17460441.2021.1918096
pubmed: 34075855
Brasil S, Pascoal C, Francisco R et al (2019) Artificial intelligence (AI) in rare diseases: Is the future brighter? Genes (Basel). 10
Brlek P, Bulić L, Bračić M et al (2024) Implementing whole genome sequencing (WGS) in clinical practice: advantages, challenges, and future perspectives. Cells 13. https://doi.org/10.3390/cells13060504
Buckle A, Brackley CA, Boyle S et al (2018) Polymer simulations of heteromorphic chromatin predict the 3D folding of Complex genomic loci. Mol Cell 72:786–797e11. https://doi.org/10.1016/j.molcel.2018.09.016
doi: 10.1016/j.molcel.2018.09.016
pubmed: 30344096
pmcid: 6242782
Byron SA, Van Keuren-Jensen KR, Engelthaler DM et al (2016) Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet 17
Cameron DE, Bashor CJ, Collins JJ (2014) A brief history of synthetic biology. Nat Rev Microbiol 12:381–390
doi: 10.1038/nrmicro3239
pubmed: 24686414
Cao F, Zhang Y, Cai Y et al (2021) Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequences. Genome Biol 22:1–25. https://doi.org/10.1186/s13059-021-02453-5
doi: 10.1186/s13059-021-02453-5
Carrer A, Romaniello MG, Calderara ML et al (2023) Application of the Face2Gene tool in an Italian dysmorphological pediatric clinic: retrospective validation and future perspectives. Am J Med Genet Part A 194. https://doi.org/10.1002/ajmg.a.63459
Castillo-Hair SM, Seelig G (2022) Machine learning for Designing Next-Generation mRNA therapeutics. Acc Chem Res 55:24–34. https://doi.org/10.1021/acs.accounts.1c00621
doi: 10.1021/acs.accounts.1c00621
pubmed: 34905691
Cembrowska-Lech D, Krzemińska A, Miller T et al (2023) An Integrated Multi-omics and Artificial Intelligence Framework for Advance Plant phenotyping in horticulture. Biology (Basel) 12. https://doi.org/10.3390/biology12101298
Chabon JJ, Hamilton EG, Kurtz DM et al (2020) Integrating genomic features for non-invasive early lung cancer detection. Nature 580. https://doi.org/10.1038/s41586-020-2140-0
Chaudhary K, Poirion OB, Lu L, Garmire LX (2018) Deep learning–based multi-omics integration robustly predicts survival in liver cancer. Clin Cancer Res 24. https://doi.org/10.1158/1078-0432.CCR-17-0853
Chen J, Zang Z, Braun U et al (2020) Association of a reproducible Epigenetic Risk Profile for Schizophrenia with Brain methylation and function. JAMA Psychiatry 77. https://doi.org/10.1001/jamapsychiatry.2019.4792
Chen L, Saykin AJ, Yao B, Zhao F (2022) Multi-task deep autoencoder to predict Alzheimer’s disease progression using temporal DNA methylation data in peripheral blood. Comput Struct Biotechnol J 20. https://doi.org/10.1016/j.csbj.2022.10.016
Chen M, Liu X, Liu Q et al (2023) 3D genomics and its applications in precision medicine. Cell Mol Biol Lett 28:1–26
doi: 10.1186/s11658-023-00428-x
Chong LC, Gandhi G, Lee JM et al (2021) Drug discovery of spinal muscular atrophy (sma) in computational perspective: a comprehensive review. Int J Mol Sci 22
Chu DKW, Hui KPY, Perera RAPM et al (2018) MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A 115:3144–3149. https://doi.org/10.1073/pnas.1718769115
doi: 10.1073/pnas.1718769115
pubmed: 29507189
pmcid: 5866576
Chuai G, Ma H, Yan J et al (2018) DeepCRISPR: optimized CRISPR guide RNA design by deep learning. Genome Biol. https://doi.org/10.1186/s13059-018-1459-4 . 19:
doi: 10.1186/s13059-018-1459-4
pubmed: 29945655
pmcid: 6020378
Ciancia S, Goedegebuure WJ, Grootjen LN et al (2023) Computer-aided facial analysis as a tool to identify patients with silver–Russell syndrome and prader–Willi syndrome. Eur J Pediatr 182:2607–2614. https://doi.org/10.1007/s00431-023-04937-x
doi: 10.1007/s00431-023-04937-x
pubmed: 36947243
pmcid: 10257592
Cilluffo G, Fasola S, Ferrante G et al (2021a) Machine learning: an overview and applications in pharmacogenetics. Genes (Basel) 12:1511
doi: 10.3390/genes12101511
pubmed: 34680905
Cilluffo G, Fasola S, Ferrante G et al (2021b) Machine learning: an overview and applications in pharmacogenetics. Genes (Basel) 12:1–12. https://doi.org/10.3390/genes12101511
doi: 10.3390/genes12101511
Cohen JD, Li L, Wang Y et al (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science (80-) 359:. https://doi.org/10.1126/science.aar3247
Coler EA, Chen W, Melnik AV et al (2024) Metabolomics in the era of artificial intelligence. https://doi.org/10.1530/mah-23-0017 . Microbiota Host 2:
Coudray N, Ocampo PS, Sakellaropoulos T et al (2018) Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning. Nat Med 24. https://doi.org/10.1038/s41591-018-0177-5
Crow RA, Hart KA, McDermott MP et al (2018) A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial. Trials 19
Davenport T, Kalakota R (2019) The potential for artificial intelligence in healthcare. Futur Healthc J 6:94–98. https://doi.org/10.7861/futurehosp.6-2-94
doi: 10.7861/futurehosp.6-2-94
Day S, Jonker AH, Lau LPL et al (2018) Recommendations for the design of small population clinical trials. Orphanet J Rare Dis 13. https://doi.org/10.1186/s13023-018-0931-2
De La Vega FM, Chowdhury S, Moore B et al (2021) Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases. Genome Med 13:1–19. https://doi.org/10.1186/s13073-021-00965-0
doi: 10.1186/s13073-021-00965-0
Deeni Y, Beccari T, Dundar M et al (2014) Novel technologies and their applications in biotechnology and the life sciences. J Biotechnol 185:S12. https://doi.org/10.1016/j.jbiotec.2014.07.043
doi: 10.1016/j.jbiotec.2014.07.043
Dias R, Torkamani A (2019) Artificial intelligence in clinical and genomic diagnostics. Genome Med. 11
Dimauro G, Colagrande P, Carlucci R et al (2019) Crisprlearner: a deep learning-based system to predict crispr/cas9 sgrna on-target cleavage efficiency. Electron 8. https://doi.org/10.3390/electronics8121478
Ding L, Bailey MH, Porta-Pardo E et al (2018) Perspective on oncogenic processes at the end of the beginning of Cancer Genomics. https://doi.org/10.1016/j.cell.2018.03.033 . Cell 173:
Dlamini Z, Francies FZ, Hull R, Marima R (2020) Artificial intelligence (AI) and big data in cancer and precision oncology. Comput Struct Biotechnol J 18
Du J, Yang YC, An ZJ et al (2023) Advances in spatial transcriptomics and related data analysis strategies. J Transl Med 21
Duncan JL, Pierce EA, Laster AM et al (2018) Inherited retinal degenerations: current landscape and knowledge gaps. Transl Vis Sci Technol 7:6–6. https://doi.org/10.1167/tvst.7.4.6
doi: 10.1167/tvst.7.4.6
pubmed: 30034950
pmcid: 6052953
Dundar M, Emirogullari EF (2012) Biotechnology, cloning and ethics. Hum Evol 27:179–182
Dundar M, Prakash S, Lal R, Martin DK (2019) Future biotechnology. Eurobiotech J 3:53–56
doi: 10.2478/ebtj-2019-0006
Dundar MS, Yildirim AB, Yildirim DT et al (2024) Artificial cells: a potentially groundbreaking field of research and therapy. Eurobiotech J 8:55–64. https://doi.org/10.2478/ebtj-2024-0006
doi: 10.2478/ebtj-2024-0006
Erfanian N, Heydari AA, Feriz AM et al (2023) Deep learning applications in single-cell genomics and transcriptomics data analysis. Biomed Pharmacother 165
Eslami M, Adler A, Caceres RS et al (2022) Artificial intelligence for synthetic biology. Commun ACM 65:88–97. https://doi.org/10.1145/3500922
doi: 10.1145/3500922
Fabbri C, Corponi F, Albani D et al (2018) Pleiotropic genes in psychiatry: calcium channels and the stress-related FKBP5 gene in antidepressant resistance. Prog Neuro-Psychopharmacology Biol Psychiatry 81:203–210. https://doi.org/10.1016/j.pnpbp.2017.10.005
doi: 10.1016/j.pnpbp.2017.10.005
Feil R, Fraga MF (2012) Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 13
Ferreira CR (2019) The burden of rare diseases. Am J Med Genet Part A 179:885–892
doi: 10.1002/ajmg.a.61124
pubmed: 30883013
Foksinska A, Crowder CM, Crouse AB et al (2022) The precision medicine process for treating rare disease using the artificial intelligence tool mediKanren. Front Artif Intell 5. https://doi.org/10.3389/frai.2022.910216
Fudenberg G, Kelley DR, Pollard KS (2020) Predicting 3D genome folding from DNA sequence with Akita. Nat Methods 17:1111–1117. https://doi.org/10.1038/s41592-020-0958-x
doi: 10.1038/s41592-020-0958-x
pubmed: 33046897
pmcid: 8211359
Galal A, Talal M, Moustafa A (2022) Applications of machine learning in metabolomics: Disease modeling and classification. Front Genet 13
Gao D, Morini E, Salani M et al (2021) A deep learning approach to identify gene targets of a therapeutic for human splicing disorders. Nat Commun 12. https://doi.org/10.1038/s41467-021-23663-2
García Martín H, Mazurenko S, Zhao H (2024) Special issue on Artificial Intelligence for Synthetic Biology. ACS Synth Biol 13
Gargano MA, Matentzoglu N, Coleman B et al (2024) The human phenotype ontology in 2024: phenotypes around the world. Nucleic Acids Res 52. https://doi.org/10.1093/nar/gkad1005
Gartland KMA, Dundar M, Beccari T et al (2017) Advances in biotechnology: Genomics and genome editing. EuroBiotech J 1:2–9. https://doi.org/10.24190/issn2564-615x/2017/01.02
doi: 10.24190/issn2564-615x/2017/01.02
Gilbert-Barness E (2010) Teratogenic causes of malformations. Ann Clin Lab Sci 40:99–114
pubmed: 20421621
Giudice M, Del, Peirone S, Perrone S et al (2021) Artificial intelligence in bulk and single-cell rna-sequencing data to foster precision oncology. Int J Mol Sci 22
Gomes B, Ashley EA (2023) Artificial Intelligence in Molecular Medicine. N Engl J Med 388:2456–2465. https://doi.org/10.1056/nejmra2204787
doi: 10.1056/nejmra2204787
pubmed: 37379136
Gordon ES, Babu D, Laney DA (2018) The future is now: Technology’s impact on the practice of genetic counseling. Am. J. Med. Genet. Part C Semin. Med. Genet. 178
Gottlieb A, Stein GY, Ruppin E, Sharan R (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 7. https://doi.org/10.1038/msb.2011.26
Greatbatch O, Garrett A, Snape K (2019) The impact of artificial intelligence on the current and future practice of clinical cancer genomics. Genet Res (Camb) 101:e9
doi: 10.1017/S0016672319000089
pubmed: 31668155
Güell M, Yang L, Church GM (2014) Genome editing assessment using CRISPR Genome Analyzer (CRISPR-GA). Bioinformatics 30:2968–2970. https://doi.org/10.1093/bioinformatics/btu427
doi: 10.1093/bioinformatics/btu427
pubmed: 24990609
pmcid: 4184265
Gunasekara CJ, Hannon E, MacKay H et al (2021) A machine learning case–control classifier for schizophrenia based on DNA methylation in blood. Transl Psychiatry 11. https://doi.org/10.1038/s41398-021-01496-3
Gurovich Y, Hanani Y, Bar O et al (2019a) Identifying facial phenotypes of genetic disorders using deep learning. Nat Med 25:60–64. https://doi.org/10.1038/s41591-018-0279-0
doi: 10.1038/s41591-018-0279-0
pubmed: 30617323
Gurovich Y, Hanani Y, Bar O et al (2019b) Identifying facial phenotypes of genetic disorders using deep learning. Nat Med 25:60–64. https://doi.org/10.1038/s41591-018-0279-0
doi: 10.1038/s41591-018-0279-0
pubmed: 30617323
Hao J, Kim Y, Kim TK, Kang M (2018) PASNet: pathway-associated sparse deep neural network for prognosis prediction from high-throughput data. BMC Bioinformatics 19. https://doi.org/10.1186/s12859-018-2500-z
Hart TC, Hart PS (2009) Genetic studies of craniofacial anomalies: clinical implications and applications. Orthod Craniofac Res 12:212–220
doi: 10.1111/j.1601-6343.2009.01455.x
pubmed: 19627523
pmcid: 4617229
He X, Liu X, Zuo F et al (2023) Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol 88:187–200
doi: 10.1016/j.semcancer.2022.12.009
pubmed: 36596352
He D, Wang R, Xu Z et al (2024) The use of artificial intelligence in the treatment of rare diseases: a scoping review. Intractable Rare Dis Res 13:12–22
doi: 10.5582/irdr.2023.01111
pubmed: 38404730
pmcid: 10883845
Hınçer A, Ahan RE, Aras E, Şeker UÖŞ (2023) Making the next generation of therapeutics: mRNA meets Synthetic Biology. ACS Synth Biol 12:2505–2515
doi: 10.1021/acssynbio.3c00253
pubmed: 37672348
pmcid: 10510722
Horman WSJ, Nguyen THO, Kedzierska K et al (2018) The drivers of pathology in zoonotic avian influenza: the interplay between host and pathogen. Front Immunol 9
Hovenga V, Kalita J, Oluwadare O (2023) HiC-GNN: a generalizable model for 3D chromosome reconstruction using graph convolutional neural networks. Comput Struct Biotechnol J 21:812–836. https://doi.org/10.1016/j.csbj.2022.12.051
doi: 10.1016/j.csbj.2022.12.051
pubmed: 36698967
Hsieh T-C, Bar-Haim A, Moosa S et al (2021) GestaltMatcher: Overcoming the limits of rare disease matching using facial phenotypic descriptors. medRxiv
Huang Y, Sun X, Jiang H et al (2021) A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer’s disease. Nat Commun 12. https://doi.org/10.1038/s41467-021-24710-8
Hull R, Ramagaga S, Nkosi N et al (2023) Epigenetics Analysis Using Artificial Intelligence in the era of Precision Oncology. Artificial Intelligence and Precision Oncology. Bridging Cancer Research and Clinical Decision Support
Hulsen T, Jamuar SS, Moody AR et al (2019) From big data to precision medicine. Front Med 6
Hunter AGW (2002) Medical genetics: 2. The diagnostic approach to the child with dysmorphic signs. C Can Med Assoc J 167:367–372
Ioannidis NM, Rothstein JH, Pejaver V et al (2016) REVEL: an Ensemble Method for Predicting the pathogenicity of rare missense variants. Am J Hum Genet 99. https://doi.org/10.1016/j.ajhg.2016.08.016
Ireland D, Bradford DK, Szepe E et al (2021) Introducing Edna: a trainee chatbot designed to support communication about additional (secondary) genomic findings. Patient Educ Couns 104:739–749. https://doi.org/10.1016/j.pec.2020.11.007
doi: 10.1016/j.pec.2020.11.007
pubmed: 33234441
Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF et al (2019) Predicting Splicing from primary sequence with deep learning. https://doi.org/10.1016/j.cell.2018.12.015 . Cell 176:
Ji Y, Zhou Z, Liu H, Davuluri RV (2021) DNABERT: pre-trained bidirectional encoder representations from transformers model for DNA-language in genome. Bioinformatics 37:2112–2120. https://doi.org/10.1093/bioinformatics/btab083
doi: 10.1093/bioinformatics/btab083
pubmed: 33538820
pmcid: 11025658
Jones BA, Grace D, Kock R et al (2013) Zoonosis emergence linked to agricultural intensification and environmental change. Proc Natl Acad Sci U S A 110:8399–8404. https://doi.org/10.1073/pnas.1208059110
doi: 10.1073/pnas.1208059110
pubmed: 23671097
pmcid: 3666729
Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583–589. https://doi.org/10.1038/s41586-021-03819-2
doi: 10.1038/s41586-021-03819-2
pubmed: 34265844
pmcid: 8371605
Kalil AC, Patterson TF, Mehta AK et al (2021) Baricitinib plus Remdesivir for hospitalized adults with Covid-19. N Engl J Med 384:795–807. https://doi.org/10.1056/nejmoa2031994
doi: 10.1056/nejmoa2031994
pubmed: 33306283
Kang M, Ko E, Mersha TB (2022) A roadmap for multi-omics data integration using deep learning. Brief Bioinform 23
Karim MR, Islam T, Shajalal M et al (2023) Explainable AI for Bioinformatics: methods, tools and applications. Brief Bioinform 24. https://doi.org/10.1093/bib/bbad236
Kautzky A, Baldinger P, Souery D et al (2015) The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression. Eur Neuropsychopharmacol 25:441–453. https://doi.org/10.1016/j.euroneuro.2015.01.001
doi: 10.1016/j.euroneuro.2015.01.001
pubmed: 25769916
Kearney E, Wojcik A, Babu D (2020) Artificial intelligence in genetic services delivery: Utopia or apocalypse? J Genet Couns 29. https://doi.org/10.1002/jgc4.1192
Keesing F, Ostfeld RS (2021) Impacts of biodiversity and biodiversity loss on zoonotic diseases. Proc. Natl. Acad. Sci. U. S. A. 118
Kenanoglu S, Gokce N, Akalin H et al (2022) Implication of the Mediterranean diet on the human epigenome. J Prev Med Hyg 63:E44–E55
pubmed: 36479488
pmcid: 9710399
Kim YR, Kim D, Kim SY (2019) Prediction of acquired taxane resistance using a personalized pathway-based machine learning method. Cancer Res Treat 51:672–684. https://doi.org/10.4143/crt.2018.137
doi: 10.4143/crt.2018.137
pubmed: 30092623
Klein TE, Chang JT, Cho MK et al (2001) Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenomics J 1:167–170. https://doi.org/10.1038/sj.tpj.6500035
doi: 10.1038/sj.tpj.6500035
pubmed: 11908751
Korfmann K, Gaggiotti OE, Fumagalli M (2023) Deep learning in Population Genetics. Genome Biol Evol 15
Kuang S, Wang L (2021) Deep learning of sequence patterns for CCCTC-Binding factor-mediated chromatin Loop formation. J Comput Biol 28:133–145. https://doi.org/10.1089/cmb.2020.0225
doi: 10.1089/cmb.2020.0225
pubmed: 33232622
Lee M (2023) Deep learning in CRISPR-Cas systems: a review of recent studies. Front Bioeng Biotechnol 11
Lee Ysuk, Krishnan A, Oughtred R et al (2019) A computational Framework for Genome-wide characterization of the Human Disease Landscape. Cell Syst 8:152–162e6. https://doi.org/10.1016/j.cels.2018.12.010
doi: 10.1016/j.cels.2018.12.010
pubmed: 30685436
pmcid: 7374759
Li Q, Ren Z, Cao K et al (2022a) CancerVar: an artificial intelligence–empowered platform for clinical interpretation of somatic mutations in cancer. Sci Adv 8. https://doi.org/10.1126/sciadv.abj1624
Li R, Li L, Xu Y, Yang J (2022b) Machine learning meets omics: applications and perspectives. Brief Bioinform 23
Li Y, Stanojevic S, Garmire LX (2022c) Emerging artificial intelligence applications in spatial transcriptomics analysis. Comput Struct Biotechnol J 20:2895–2908
doi: 10.1016/j.csbj.2022.05.056
pubmed: 35765645
pmcid: 9201012
Liang L, Rasmussen MLH, Piening B et al (2020) Metabolic Dynamics and Prediction of gestational age and Time to delivery in pregnant women. Cell 181:1680–1692e15. https://doi.org/10.1016/j.cell.2020.05.002
doi: 10.1016/j.cell.2020.05.002
pubmed: 32589958
pmcid: 7327522
Liao WW, Asri M, Ebler J et al (2023) A draft human pangenome reference. Nature 617:312–324. https://doi.org/10.1038/s41586-023-05896-x
doi: 10.1038/s41586-023-05896-x
pubmed: 37165242
pmcid: 10172123
Liñares-Blanco J, Pazos A, Fernandez-Lozano C (2021) Machine learning analysis of TCGA cancer data. PeerJ Comput Sci 7. https://doi.org/10.7717/PEERJ-CS.584
Liu D, Schilling B, Liu D et al (2019) Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med 25:1916–1927. https://doi.org/10.1038/s41591-019-0654-5
doi: 10.1038/s41591-019-0654-5
pubmed: 31792460
pmcid: 6898788
Logviss K, Krievins D, Purvina S (2018) Characteristics of clinical trials in rare vs. common diseases: a register-based Latvian study. PLoS ONE 13. https://doi.org/10.1371/journal.pone.0194494
López-Cortés A, Paz-y-Miño C, Cabrera-Andrade A et al (2018) Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis. Sci Rep 8. https://doi.org/10.1038/s41598-018-35149-1
López-Cortés A, Cabrera-Andrade A, Vázquez-Naya JM et al (2020) Prediction of breast cancer proteins involved in immunotherapy, metastasis, and RNA-binding using molecular descriptors and artificial neural networks. Sci Rep 10. https://doi.org/10.1038/s41598-020-65584-y
Lumaka A, Cosemans N, Lulebo Mampasi A et al (2017) Facial dysmorphism is influenced by ethnic background of the patient and of the evaluator. Clin Genet 92:166–171. https://doi.org/10.1111/cge.12948
doi: 10.1111/cge.12948
pubmed: 27925162
Maciukiewicz M, Marshe VS, Hauschild AC et al (2018) GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. J Psychiatr Res 99:62–68. https://doi.org/10.1016/j.jpsychires.2017.12.009
doi: 10.1016/j.jpsychires.2017.12.009
pubmed: 29407288
Maramraju S, Kowalczewski A, Kaza A et al (2024) AI-organoid integrated systems for biomedical studies and applications. Bioeng Transl Med 9
Marian AJ (2014) Sequencing your genome: what does it mean? Methodist Debakey Cardiovasc. J 10:3–6
Martinez GS, Dutt M, Kelvin DJ, Kumar A (2024) PoxiPred: an Artificial-Intelligence-based method for the prediction of potential antigens and epitopes to accelerate Vaccine Development efforts against Poxviruses. Biology (Basel) 13:125. https://doi.org/10.3390/biology13020125
doi: 10.3390/biology13020125
pubmed: 38392343
McMaster ML, Berndt SI, Zhang J et al (2018) Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia. Nat Commun 9. https://doi.org/10.1038/s41467-018-06541-2
Mester R, Hou K, Ding Y et al (2023) Impact of cross-ancestry genetic architecture on GWASs in admixed populations. Am J Hum Genet 110:927–939. https://doi.org/10.1016/j.ajhg.2023.05.001
doi: 10.1016/j.ajhg.2023.05.001
pubmed: 37224807
pmcid: 10257009
Mishima H, Suzuki H, Doi M et al (2019) Evaluation of Face2Gene using facial images of patients with congenital dysmorphic syndromes recruited in Japan. J Hum Genet 64:789–794. https://doi.org/10.1038/s10038-019-0619-z
doi: 10.1038/s10038-019-0619-z
pubmed: 31138847
Modi K, Singh I, Kumar Y (2023) A Comprehensive Analysis of Artificial Intelligence Techniques for the prediction and prognosis of Lifestyle diseases. Arch Comput Methods Eng 30:4733–4756
doi: 10.1007/s11831-023-09957-2
Mohanta TK, Mishra AK, Al-Harrasi A (2021) The 3d genome: from structure to function. Int J Mol Sci 22
Monsalve D, Mesa A, Mira LM et al (2024) Antimicrobial peptides designed by computational analysis of proteomes. Antonie Van Leeuwenhoek. Int J Gen Mol Microbiol 117. https://doi.org/10.1007/s10482-024-01946-0
Moser T, Kühberger S, Lazzeri I et al (2023) Bridging biological cfDNA features and machine learning approaches. Trends Genet 39
Mund A, Coscia F, Kriston A et al (2022) Deep visual proteomics defines single-cell identity and heterogeneity. Nat Biotechnol 40:1231–1240. https://doi.org/10.1038/s41587-022-01302-5
doi: 10.1038/s41587-022-01302-5
pubmed: 35590073
pmcid: 9371970
Nazareth S, Nussbaum RL, Siglen E, Wicklund CA (2021) Chatbots & artificial intelligence to scale genetic information delivery. In: Journal of Genetic Counseling
Newman AM, Liu CL, Green MR et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453–457. https://doi.org/10.1038/nmeth.3337
doi: 10.1038/nmeth.3337
pubmed: 25822800
pmcid: 4739640
Newman AM, Steen CB, Liu CL et al (2019) Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol 37. https://doi.org/10.1038/s41587-019-0114-2
Osanlou R, Walker L, Hughes DA et al (2022) Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open 12:e055551. https://doi.org/10.1136/BMJOPEN-2021-055551
doi: 10.1136/BMJOPEN-2021-055551
pubmed: 35788071
pmcid: 9255409
Ostroverkhova D, Przytycka TM, Panchenko AR (2023) Cancer driver mutations: predictions and reality. Trends Mol Med 29:554–566
doi: 10.1016/j.molmed.2023.03.007
pubmed: 37076339
Pillai N, Ramkumar M, Nanduri B (2022) Artificial Intelligence Models for Zoonotic Pathogens: A Survey. Microorganisms 10
Pirmohamed M (2023) Pharmacogenomics: current status and future perspectives. Nat Rev Genet 24:350–362
doi: 10.1038/s41576-022-00572-8
pubmed: 36707729
Pirmohamed M, James S, Meakin S et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 329:15–19. https://doi.org/10.1136/bmj.329.7456.15
doi: 10.1136/bmj.329.7456.15
PONTIKOS N, Woof W, Krawitz P et al (2022) Eye2Gene: prediction of causal inherited retinal disease gene from multimodal imaging using AI. Invest Ophthalmol Vis Sci 63:1161. https://doi.org/10.21203/RS.3.RS-2110140/V1
doi: 10.21203/RS.3.RS-2110140/V1
Poplin R, Chang PC, Alexander D et al (2018) A universal snp and small-indel variant caller using deep neural networks. Nat Biotechnol 36:983. https://doi.org/10.1038/nbt.4235
doi: 10.1038/nbt.4235
pubmed: 30247488
Posey JE, Harel T, Liu P et al (2017) Resolution of Disease Phenotypes resulting from Multilocus genomic variation. N Engl J Med 376. https://doi.org/10.1056/nejmoa1516767
Rendeiro AF, Schmidl C, Strefford JC et al (2016) Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks. Nat Commun 7. https://doi.org/10.1038/NCOMMS11938
Rhoads DD (2020) Computer vision and artificial intelligence are emerging diagnostic tools for the clinical microbiologist. J Clin Microbiol 58
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30
doi: 10.1038/gim.2015.30
pubmed: 25741868
pmcid: 4544753
Richardson PJ, Smith DP, de Giorgio A et al (2023) Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis. Transl Neurodegener 12
Saal HM (2016) Genetic evaluation for Craniofacial conditions. Facial plast. Surg Clin North Am 24:405–425
Schubach M, Maass T, Nazaretyan L et al (2024) CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res 52:D1143–D1154. https://doi.org/10.1093/nar/gkad989
doi: 10.1093/nar/gkad989
pubmed: 38183205
pmcid: 10767851
Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) Mutationtaster2: mutation prediction for the deep-sequencing age. Nat Methods 11
Schwessinger R, Gosden M, Downes D et al (2020) DeepC: predicting 3D genome folding using megabase-scale transfer learning. Nat Methods 17:1118–1124. https://doi.org/10.1038/s41592-020-0960-3
doi: 10.1038/s41592-020-0960-3
pubmed: 33046896
pmcid: 7610627
Shahbazy M, Ramarathinam SH, Li C et al (2024) MHCpLogics: an interactive machine learning-based tool for unsupervised data visualization and cluster analysis of immunopeptidomes. Brief Bioinform 25. https://doi.org/10.1093/bib/bbae087
Siglen E, Vetti HH, Augestad M et al (2023) Evaluation of the Rosa Chatbot Providing Genetic Information to patients at risk of Hereditary breast and ovarian Cancer: qualitative interview study. J Med Internet Res 25. https://doi.org/10.2196/46571
Smedley D, Jacobsen JOB, Jäger M et al (2015) Next-generation diagnostics and disease-gene discovery with the Exomiser. Nat Protoc 10. https://doi.org/10.1038/nprot.2015.124
Smith KP, Wang H, Durant TJS et al (2020) Applications of Artificial Intelligence in Clinical Microbiology Diagnostic Testing. Clin Microbiol Newsl 42. https://doi.org/10.1016/j.clinmicnews.2020.03.006
Solomon BD, Adam MP, Fong CT et al (2023) Perspectives on the future of dysmorphology. Am J Med Genet Part A 191. https://doi.org/10.1002/ajmg.a.63060
Soori M, Arezoo B, Dastres R (2023) Artificial intelligence, machine learning and deep learning in advanced robotics, a review. Cogn Robot 3:54–70
doi: 10.1016/j.cogr.2023.04.001
Su R, Liu X, Wei L, Zou Q (2019) Deep-Resp-Forest: a deep forest model to predict anti-cancer drug response. Methods 166:91–102. https://doi.org/10.1016/j.ymeth.2019.02.009
doi: 10.1016/j.ymeth.2019.02.009
pubmed: 30772464
Sun YV, Hu YJ (2016) Adv Genet 93:147–190. https://doi.org/10.1016/bs.adgen.2015.11.004 . Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases
Sun D, Wang M, Li A (2019) A multimodal deep neural network for human breast Cancer Prognosis Prediction by integrating Multi-dimensional Data. IEEE/ACM Trans Comput Biol Bioinforma 16:841–850. https://doi.org/10.1109/TCBB.2018.2806438
doi: 10.1109/TCBB.2018.2806438
Tamborero D, Rubio-Perez C, Deu-Pons J et al (2018) Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med 10. https://doi.org/10.1186/s13073-018-0531-8
Tong Z, Zhou Y, Wang J (2019) Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine. Sci Rep 9. https://doi.org/10.1038/s41598-019-46540-x
Townsend DR, Towers DM, Lavinder JJ, Ippolito GC (2024) Innovations and trends in antibody repertoire analysis. Curr Opin Biotechnol 86
Vinciguerra M (2023) The potential for Artificial Intelligence Applied to Epigenetics. Mayo Clin Proc Digit Heal. https://doi.org/10.1016/j.mcpdig.2023.07.005 . 1:
doi: 10.1016/j.mcpdig.2023.07.005
Visibelli A, Roncaglia B, Spiga O, Santucci A (2023) The Impact of Artificial Intelligence in the Odyssey of Rare Diseases. Biomedicines 11
Wang T, Antonacci-Fulton L, Howe K et al (2022) The human pangenome project: a global resource to map genomic diversity. Nature 604:437–446
doi: 10.1038/s41586-022-04601-8
pubmed: 35444317
pmcid: 9402379
Wang R, Helbig I, Edmondson AC et al (2023) Splicing defects in rare diseases: transcriptomics and machine learning strategies towards genetic diagnosis. Brief Bioinform 24
Whalen S, Truty RM, Pollard KS (2016) Enhancer-promoter interactions are encoded by complex genomic signatures on looping chromatin. Nat Genet 48:488–496. https://doi.org/10.1038/ng.3539
doi: 10.1038/ng.3539
pubmed: 27064255
pmcid: 4910881
Wojtara M, Rana E, Rahman T et al (2023) Artificial intelligence in rare disease diagnosis and treatment. Clin Transl Sci 16:2106–2111
doi: 10.1111/cts.13619
pubmed: 37646577
pmcid: 10651639
Wolffe AP, Guschin D (2000) Review: chromatin structural features and targets that regulate transcription. J Struct Biol 129. https://doi.org/10.1006/jsbi.2000.4217
Xu J, Yang P, Xue S et al (2019) Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Hum Genet 138:109–124
doi: 10.1007/s00439-019-01970-5
pubmed: 30671672
pmcid: 6373233
Yang M, Ma J (2022) Machine learning methods for exploring sequence determinants of 3D Genome Organization. J Mol Biol 434:167666
doi: 10.1016/j.jmb.2022.167666
pubmed: 35659533
Yaoyu F, Xiao L (2011) Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev 24:110–140. https://doi.org/10.1128/CMR.00033-10
doi: 10.1128/CMR.00033-10
Zemojtel T, Köhler S, Mackenroth L et al (2014) Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome. Sci Transl Med 6. https://doi.org/10.1126/scitranslmed.3009262
Zeng J, Xue A, Jiang L et al (2021) Widespread signatures of natural selection across human complex traits and functional genomic categories. Nat Commun 12. https://doi.org/10.1038/s41467-021-21446-3
Zhang Y (2017) Investigate genomic 3D structure using deep neural network. PhD Thesis
Zhou J (2022) Sequence-based modeling of three-dimensional genome architecture from kilobase to chromosome scale. Nat Genet 54:725–734. https://doi.org/10.1038/s41588-022-01065-4
doi: 10.1038/s41588-022-01065-4
pubmed: 35551308
pmcid: 9186125
Zhu S, Jiang Y, Xu K et al (2020) The progress of gut microbiome research related to brain disorders. J Neuroinflammation 17